BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27264242)

  • 1. The emerging roles of orphan nuclear receptors in prostate cancer.
    Wu D; Cheung A; Wang Y; Yu S; Chan FL
    Biochim Biophys Acta; 2016 Aug; 1866(1):23-36. PubMed ID: 27264242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytosterols activating nuclear receptors are involving in steroid hormone-dependent cancers: Myth or fact?
    Bakrim S; El Omari N; Khan EJ; Khalid A; Abdalla AN; Chook JB; Goh KW; Ming LC; Aboulaghras S; Bouyahya A
    Biomed Pharmacother; 2023 Dec; 169():115783. PubMed ID: 37944439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily-Update 2023.
    Burris TP; de Vera IMS; Cote I; Flaveny CA; Wanninayake US; Chatterjee A; Walker JK; Steinauer N; Zhang J; Coons LA; Korach KS; Cain DW; Hollenberg AN; Webb P; Forrest D; Jetten AM; Edwards DP; Grimm SL; Hartig S; Lange CA; Richer JK; Sartorius CA; Tetel M; Billon C; Elgendy B; Hegazy L; Griffett K; Peinetti N; Burnstein KL; Hughes TS; Sitaula S; Stayrook KR; Culver A; Murray MH; Finck BN; Cidlowski JA
    Pharmacol Rev; 2023 Nov; 75(6):1233-1318. PubMed ID: 37586884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General molecular biology and architecture of nuclear receptors.
    Pawlak M; Lefebvre P; Staels B
    Curr Top Med Chem; 2012; 12(6):486-504. PubMed ID: 22242852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonists, Inverse Agonists, and Antagonists as Therapeutic Approaches to Manipulate Retinoic Acid-Related Orphan Receptors (RORs).
    Nematisouldaragh D; Nguyen H; Rabinovich-Nikitin I
    Can J Physiol Pharmacol; 2024 May; ():. PubMed ID: 38728749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural compounds targeting nuclear receptors for effective cancer therapy.
    Hegde M; Girisa S; Naliyadhara N; Kumar A; Alqahtani MS; Abbas M; Mohan CD; Warrier S; Hui KM; Rangappa KS; Sethi G; Kunnumakkara AB
    Cancer Metastasis Rev; 2023 Sep; 42(3):765-822. PubMed ID: 36482154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orphan nuclear receptors joining the reprogramming club.
    Ng HH
    Nat Cell Biol; 2024 Feb; 26(2):171. PubMed ID: 38307997
    [No Abstract]   [Full Text] [Related]  

  • 8. Structural and functional characterization of the endogenous agonist for orphan receptor GPR3.
    Chen G; Staffen N; Wu Z; Xu X; Pan J; Inoue A; Shi T; Gmeiner P; Du Y; Xu J
    Cell Res; 2024 Mar; 34(3):262-265. PubMed ID: 38287118
    [No Abstract]   [Full Text] [Related]  

  • 9. PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer.
    Raina K; Lu J; Qian Y; Altieri M; Gordon D; Rossi AM; Wang J; Chen X; Dong H; Siu K; Winkler JD; Crew AP; Crews CM; Coleman KG
    Proc Natl Acad Sci U S A; 2016 Jun; 113(26):7124-9. PubMed ID: 27274052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription.
    Jia L; Wu D; Wang Y; You W; Wang Z; Xiao L; Cai G; Xu Z; Zou C; Wang F; Teoh JY; Ng CF; Yu S; Chan FL
    Oncogene; 2018 Jun; 37(25):3340-3355. PubMed ID: 29555975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear receptor profiling in prostatospheroids and castration-resistant prostate cancer.
    Wang Z; Wu D; Ng CF; Teoh JY; Yu S; Wang Y; Chan FL
    Endocr Relat Cancer; 2018 Jan; 25(1):35-50. PubMed ID: 29042395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay between orphan nuclear receptors and androgen receptor-dependent or-independent growth signalings in prostate cancer.
    Wang Y; Gao W; Li Y; Chow ST; Xie W; Zhang X; Zhou J; Chan FL
    Mol Aspects Med; 2021 Apr; 78():100921. PubMed ID: 33121737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low expression of NR1D1 and NR2E3 is associated with advanced features of retinoblastoma.
    Ding J; Sun J; Ma RQ; Zheng K; Han YN
    Int Ophthalmol; 2024 Mar; 44(1):133. PubMed ID: 38480634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of GLI Transcriptional Activity and Prostate Cancer Cell Growth and Proliferation by DAX1.
    Hong SP; Kim KW; Ahn SK
    Curr Issues Mol Biol; 2023 Jun; 45(7):5347-5361. PubMed ID: 37504255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcellular dynamics of estrogen-related receptors involved in transrepression through interactions with scaffold attachment factor B1.
    Tanida T; Matsuda KI; Uemura T; Yamaguchi T; Hashimoto T; Kawata M; Tanaka M
    Histochem Cell Biol; 2021 Sep; 156(3):239-251. PubMed ID: 34129097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orphan nuclear receptors as regulators of intratumoral androgen biosynthesis in castration-resistant prostate cancer.
    Zhou J; Wang Y; Wu D; Wang S; Chen Z; Xiang S; Chan FL
    Oncogene; 2021 Apr; 40(15):2625-2634. PubMed ID: 33750894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of estrogen-related receptor alpha (ERRĪ±) inhibits gastric cancer cell migration and invasion
    Zhong Y; He K; Shi L; Chen L; Zhou B; Ma R; Yu H; Zhang J; Shuai Y; Fei Y; Lu J
    Aging (Albany NY); 2021 Feb; 13(4):5845-5857. PubMed ID: 33591949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased ABCC4 Expression Induced by ERRĪ± Leads to Docetaxel Resistance via Efflux of Docetaxel in Prostate Cancer.
    Huang H; Li J; Shen J; Lin L; Wu X; Xiang S; Li Y; Xu Y; Zhao Q; Zhao Y; Kaboli PJ; Li M; Li X; Wang W; Wen Q; Xiao Z
    Front Oncol; 2020; 10():1474. PubMed ID: 33014785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Report: central diabetes insipidus and schwannoma in a male with X-linked congenital adrenal hypoplasia.
    Seo BK; Jeong SA; Cho JY; Park JS; Seo JH; Park ES; Lim JY; Woo HO; Youn HS
    BMC Endocr Disord; 2020 May; 20(1):73. PubMed ID: 32460754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen-Related Receptor Alpha: An Under-Appreciated Potential Target for the Treatment of Metabolic Diseases.
    Tripathi M; Yen PM; Singh BK
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.